Utilization of an extra-anatomic stent (EAS) in the management of patients with advanced malignant disease
Authors:
David Němec; Jan Krhut; David Míka; Ondřej Havránek
Authors place of work:
Urologické oddělení FN, Ostrava
Published in the journal:
Ces Urol 2012; 16(4): 241-246
Category:
Original article
Summary
Aim:
Ureteral obstruction is a frequent complication in patients with malignant diseases. The most frequently used solutions are a ureteral stent, nephrostomy or open surgical intervention. An extra-anatomic stent (EAS) represent an alternative method for urinary diversion in patients with advanced malignancy and short life expectancy. The aim of this paper is to verify the efficacy of using an EAS for urinary diversion and to evaluate the quality of life (QoL) following the procedure.
Methods:
The study included 11 patients (8 men and 3 women), with a mean age of 64.5 years (38–80 years). Five patients with advanced bladder carcinoma, three patients suffered from locally advanced prostate cancer, one patient with locally advanced cervical cancer and two patients with generalized colorectal cancer. In 9 cases, patients received diversion using a urostomy bag, in 2 cases EAS was used as a bilateral nephrovesical bypass. QoL was evaluated using the King’s Health Questionnaire before and 4 weeks after treatment. The results were evaluated using the Wilcoxon test with a significance level of 0.05.
Results:
During a mean follow-up period of 40 weeks (8–55 weeks), QoL after the EAS insertion increased significantly for all parameters. Hydronephrosis was resolved by EAS insertion in 10 cases and improved in one patient. Preoperative serum creatinine level (186,6 ± 64,67 μmol/l) decreased significantly postoperatively (106 ± 24,49 μmol/l).
Conclusion:
EAS represents a promising treatment alternative for dealing with ureteral obstruction in the terminal stage of malignant diseases. The procedure is not difficult and has good functional results, with a significant increase in the quality of life for patients.
Key words:
extra-anatomic stent, ureteral obstruction, nephrostomy, Quality of Life.
Zdroje
1. Dvořáček J. Ureterální obstrukce. In Dvořáček J, Babjuk M, et al. Onkourologie. Praha: Galén 2005; 403–404.
2. Babjuk M. Derivace moči u nemocných s nádory močového měchýře. In Dvořáček J, Babjuk M, et al. Onkourologie. Praha: Galén 2005; 183–196.
3. Zimskind PD, Fetter TR, Wilkerson JL. Clinical use of long term indwelling silicone rubber ureteral splints inserted cystoscopically. J Urol 1967; 97: 840–844.
4. Kočovská P, Eret V, Toufarová P, Chudáček Z, Hora M. Možnosti endoskopického řešení dlouhodobě ponechaných inkrustovaných uretrálních stentů. Ces Urol 2012; 16(2): 101–107.
5. KHQ – http://www.nice.org.uk/nicemedia/live/10996/30291/30291.doc
6. Dindo D, Demartines N, Clavien PA. Classification of Surgical Complications, A new proposal with evaluation in a Cohort of 6336 patients and results of a survey. Ann Surg 2004; 240(2): 205–213.
7. Lingam K, Paterson PJ, Lingam MK, Buckley JF, Forrester A. Subcutaneous urinary diversion: an alternative to percutaneous nephrostomy. J Urol 1994; 152: 70–72.
8. Nissenkorn I, Gdor Y. Nephrovesical subcutaneous stent: an alternative to permanent nephrostomy. J Urol 2000; 163(2): 528–530.
9. Belej K, Záťura F, Hluší P. Možnost úpravy funkce ledvin po odstranění obstrukce. Ces Urol 2001; 2: 33–37.
10. Schmidbauer J, Kratzik C, Klinger HC, Remzi M, Lackner J, Marberger M. Nephrovesical subcutaneous ureteric bypass: long-term results in patients with advanced metastatic disease-improvement of renal function and quality of life. Eur Urol 2006; 50(5): 1073–1078.
11. Andonian S, Zorn KC, Paraskevas S, Anidjar M. Artificial ureters in renal transplantation. Urology 2005; 66: 1109.
Štítky
Paediatric urologist Nephrology UrologyČlánok vyšiel v časopise
Czech Urology
2012 Číslo 4
Najčítanejšie v tomto čísle
- Myoglobinuria as a manifestation of rhabdomyolysis following extreme physical exertion
- Nuclear medicine imaging of prostate cancer
- Treatment outcomes of BCG vaccine in patients with T1G3 urothelial cancer – a retrospective analysis
- Retroperitonal liposarcoma in the area of the lower pole of the kidney